Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001389725 | SCV001591178 | pathogenic | not provided | 2023-12-05 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Leu740Glufs*90) in the TCIRG1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 91 amino acid(s) of the TCIRG1 protein. This variant is present in population databases (no rsID available, gnomAD 0.006%). This premature translational stop signal has been observed in individuals with osteopetrosis (PMID: 30539151). ClinVar contains an entry for this variant (Variation ID: 1075994). This variant disrupts a region of the TCIRG1 protein in which other variant(s) (p.Ala796Leufs*34) have been determined to be pathogenic (PMID: 30537558). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV001826184 | SCV004205737 | pathogenic | Autosomal recessive osteopetrosis 1 | 2023-10-04 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001826184 | SCV002092933 | pathogenic | Autosomal recessive osteopetrosis 1 | 2021-03-16 | no assertion criteria provided | clinical testing |